{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:15:31Z","timestamp":1789906531435,"version":"4.0.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jcf.2023.04.002","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T18:55:44Z","timestamp":1682103344000},"page":"944-948","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Exploration of the relationship between cumulative exposure to tobramycin and ototoxicity in patients with cystic fibrosis"],"prefix":"10.1016","volume":"22","author":[{"given":"Justine","family":"Madaule","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e9lix","family":"Valenzuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Mittaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3197-8290","authenticated-orcid":false,"given":"Yohan","family":"Gallois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blandine","family":"Baladi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marl\u00e8ne","family":"Murris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Noelle","family":"Calmels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3916-577X","authenticated-orcid":false,"given":"Didier","family":"Concordet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4385-7894","authenticated-orcid":false,"given":"Peggy","family":"Gandia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jcf.2023.04.002_bib0001","article-title":"Re-evaluating aminoglycoside ototoxicity","volume":"20","author":"Staecker","year":"2021","journal-title":"J Cyst Fibros Off J Eur Cyst Fibros Soc"},{"key":"10.1016\/j.jcf.2023.04.002_bib0002","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1128\/AAC.4.4.383","article-title":"In vitro activity of ampicillin or vancomycin combined with gentamicin or streptomycin against enterococci","volume":"4","author":"Harwick","year":"1973","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jcf.2023.04.002_bib0003","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a027029","article-title":"Aminoglycosides: an Overview","volume":"6","author":"Krause","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.jcf.2023.04.002_bib0004","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/infdis\/159.2.281","article-title":"Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models","volume":"159","author":"Leggett","year":"1989","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jcf.2023.04.002_bib0005","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jcf.2020.11.020","article-title":"Ototoxicity in cystic fibrosis patients receiving intravenous tobramycin for acute pulmonary exacerbation: ototoxicity following tobramycin treatment","volume":"20","author":"Harruff","year":"2021","journal-title":"J Cyst Fibros Off J Eur Cyst Fibros Soc"},{"key":"10.1016\/j.jcf.2023.04.002_bib0006","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1021\/mp300609c","article-title":"Receptor-Mediated Endocytosis across Human Placenta: emphasis on Megalin","volume":"10","author":"Akour","year":"2013","journal-title":"Mol Pharm"},{"issue":"8849","key":"10.1016\/j.jcf.2023.04.002_bib0007","first-page":"895","article-title":"Once-daily aminoglycoside dosing","volume":"341","author":"Gonzalez","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.jcf.2023.04.002_bib0008","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0140-6736(93)90137-6","article-title":"Once versus thrice daily gentamicin in patients with serious infections","volume":"341","author":"Prins","year":"1993","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.jcf.2023.04.002_bib0009","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jcf.2017.01.006","article-title":"The cumulative effects of intravenous antibiotic treatments on hearing in patients with cystic fibrosis","volume":"16","author":"Garinis","year":"2017","journal-title":"J Cyst Fibros Off J Eur Cyst Fibros Soc"},{"key":"10.1016\/j.jcf.2023.04.002_bib0010","first-page":"e428","article-title":"Determination of a new constant to estimate glomerular filtration rate in pediatrics","volume":"119","author":"Porporato","year":"2021","journal-title":"Arch Argent Pediatr"},{"key":"10.1016\/j.jcf.2023.04.002_bib0011","unstructured":"Home n.d. https:\/\/www.biap.org\/en\/(accessed September 23, 2022)."},{"key":"10.1016\/j.jcf.2023.04.002_bib0012","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jcf.2006.12.007","article-title":"Population pharmacokinetics of tobramycin administered thrice daily and once daily in children and adults with cystic fibrosis","volume":"6","author":"Touw","year":"2007","journal-title":"J Cyst Fibros Off J Eur Cyst Fibros Soc"},{"key":"10.1016\/j.jcf.2023.04.002_bib0013","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1378\/chest.122.1.219","article-title":"Pharmacokinetics and bioavailability of aerosolized tobramycin in cystic fibrosis","volume":"122","author":"Geller","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.jcf.2023.04.002_bib0014","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jcf.2009.07.001","article-title":"Pharmacokinetics and safety of tobramycin administered by the PARI eFlow rapid nebulizer in cystic fibrosis","volume":"8","author":"Hubert","year":"2009","journal-title":"J Cyst Fibros Off J Eur Cyst Fibros Soc"},{"key":"10.1016\/j.jcf.2023.04.002_bib0015","unstructured":"Patient Registry | Cystic Fibrosis Foundation n.d. https:\/\/www.cff.org\/medical-professionals\/patient-registry (accessed September 23, 2022)."},{"key":"10.1016\/j.jcf.2023.04.002_bib0016","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jcf.2014.07.009","article-title":"High-frequency audiometry reveals high prevalence of aminoglycoside ototoxicity in children with cystic fibrosis","volume":"14","author":"Al-Malky","year":"2015","journal-title":"J Cyst Fibros Off J Eur Cyst Fibros Soc"},{"key":"10.1016\/j.jcf.2023.04.002_bib0017","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jcf.2020.07.001","article-title":"Prospective cohort study of ototoxicity in persons with cystic fibrosis following a single course of intravenous tobramycin","volume":"20","author":"Garinis","year":"2021","journal-title":"J Cyst Fibros Off J Eur Cyst Fibros Soc"},{"key":"10.1016\/j.jcf.2023.04.002_bib0018","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1179\/joc.2010.22.6.378","article-title":"Antimicrobial activity of tobramycin against respiratory cystic fibrosis Pseudomonas aeruginosa isolates from Bulgaria","volume":"22","author":"Strateva","year":"2010","journal-title":"J Chemother Florence Italy"},{"issue":"6","key":"10.1016\/j.jcf.2023.04.002_bib0019","doi-asserted-by":"crossref","first-page":"902","DOI":"10.2165\/00003495-199447060-00004","article-title":"Parenteral aminoglycoside therapy. Selection, administration and monitoring","volume":"47","author":"Kumana","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/j.jcf.2023.04.002_bib0020","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1080\/14992027.2016.1204565","article-title":"A review of the perceptual effects of hearing loss for frequencies above 3\u2009kHz","volume":"55","author":"Moore","year":"2016","journal-title":"Int J Audiol"},{"key":"10.1016\/j.jcf.2023.04.002_bib0021","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1044\/1092-4388(2007\/057)","article-title":"Contribution of high frequencies to speech recognition in quiet and noise in listeners with varying degrees of high-frequency sensorineural hearing loss","volume":"50","author":"Amos","year":"2007","journal-title":"J Speech Lang Hear Res JSLHR"},{"key":"10.1016\/j.jcf.2023.04.002_bib0022","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00280-019-04012-z","article-title":"Looking beyond the audiogram in ototoxicity associated with platinum-based chemotherapy","volume":"85","author":"Baguley","year":"2020","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jcf.2023.04.002_bib0023","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/jmg.28.2.79","article-title":"Genetic aspects of antibiotic induced deafness: mitochondrial inheritance","volume":"28","author":"Hu","year":"1991","journal-title":"J Med Genet"},{"key":"10.1016\/j.jcf.2023.04.002_bib0024","doi-asserted-by":"crossref","first-page":"20888","DOI":"10.1073\/pnas.0811258106","article-title":"Genetic analysis of interactions with eukaryotic rRNA identify the mitoribosome as target in aminoglycoside ototoxicity","volume":"105","author":"Hobbie","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcf.2023.04.002_bib0025","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.ijporl.2014.02.015","article-title":"Normal hearing in a child with the m.1555A>G mutation despite repeated exposure to aminoglycosides. Has the penetrance of this pharmacogenetic interaction been overestimated?","volume":"78","author":"Al-Malky","year":"2014","journal-title":"Int J Pediatr Otorhinolaryngol"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199323000929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199323000929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T08:18:07Z","timestamp":1756714687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199323000929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1569199323000929"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2023.04.002","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploration of the relationship between cumulative exposure to tobramycin and ototoxicity in patients with cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2023.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}